Department of Pediatric and Congenital Cardiology, University Hospital Heidelberg, Heidelberg, Germany.
Department of General Pediatrics, Division of Neuropediatrics and Metabolic Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Mol Genet Metab. 2020 May;130(1):41-48. doi: 10.1016/j.ymgme.2020.02.004. Epub 2020 Feb 10.
Propionic acidemia (PA) is an organic aciduria caused by inherited deficiency of propionyl-CoA carboxylase. Left ventricular dysfunction and QT prolongation may lead to life-threatening complications. Systematic analyses of cardiac phenotypes, in particular effects of specific cardiac therapies, are scarce.
In this longitudinal observational monocentric study (data from 1989 to 2017) all PA patients treated at our center were included. Echocardiographic parameters (left ventricular end-diastolic diameter: LVEDD, left ventricular shortening fraction, mitral valve Doppler inflow pattern) and 12‑lead electrocardiogram recordings (corrected QT interval: QTc) were analyzed. Symptomatic patients were dichotomized to the group "early-onset" (symptoms within 28 days of life) and "late-onset" (symptoms after 28 days). Associations between cardiac function, LVEDD, QTc and clinical parameters (age at onset, beta-blocker or Angiotensin-converting enzyme inhibitor = ACE-I therapy) were analyzed.
18 patients with PA were enrolled, 17 of them were symptomatic and one asymptomatic, with a median age at diagnosis of 6 days. 14/17 (82%) had early onset disease manifestation. Systolic left ventricular dysfunction (i.e. hypokinetic phenotype of cardiomyopathy) was diagnosed in 7/18 (39%) patients at a median age of 14.4 years, all had early onset. Two patients had a dilated left ventricle and systolic left ventricular dysfunction (i.e. dilated hypokinetic phenotype - dilated cardiomyopathy). Diastolic left ventricular dysfunction was found in 11/18 (61%) individuals, typically preceding systolic left ventricular dysfunction. ACE-I therapy did not improve systolic left ventricular function. Mean QTc was 445 ms (+/- 18.11 ms). Longer QTc was associated with larger LVEDD.
Systolic left ventricular dysfunction was found in 39% of patients, reflecting high disease severity. Two thirds of all individuals showed signs of diastolic left ventricular dysfunction usually preceding systolic left ventricular dysfunction; it therefore may be considered as an indicator for early cardiac disease manifestation, possibly allowing earlier treatment modification. Unresponsiveness to routine cardiac therapy highlights the need to evaluate further strategies, such as liver transplantation.
丙酸血症(PA)是一种由丙酰辅酶 A 羧化酶遗传性缺陷引起的有机酸血症。左心室功能障碍和 QT 延长可导致危及生命的并发症。系统分析心脏表型,特别是特定心脏治疗的效果,非常少见。
在这项从 1989 年到 2017 年的纵向观察性单中心研究中,纳入了在我们中心接受治疗的所有 PA 患者。分析了超声心动图参数(左心室舒张末期直径:LVEDD、左心室短轴缩短率、二尖瓣多普勒血流模式)和 12 导联心电图记录(校正 QT 间期:QTc)。将有症状的患者分为“早发型”(出生后 28 天内出现症状)和“晚发型”(出生后 28 天后出现症状)两组。分析了心脏功能、LVEDD、QTc 与临床参数(发病年龄、β受体阻滞剂或血管紧张素转换酶抑制剂[ACE-I]治疗)之间的相关性。
共纳入 18 例 PA 患者,其中 17 例为有症状患者,1 例为无症状患者,中位诊断年龄为 6 天。17 例中有 14 例(82%)为早发型疾病表现。18 例患者中有 7 例(39%)在中位年龄 14.4 岁时被诊断为收缩期左心室功能障碍(即心肌病的运动不良表型),均为早发型。2 例患者为左心室扩张伴收缩期左心室功能障碍(即扩张性运动不良表型-扩张型心肌病)。18 例中有 11 例(61%)存在舒张期左心室功能障碍,通常早于收缩期左心室功能障碍。ACE-I 治疗并未改善收缩期左心室功能。平均 QTc 为 445ms(+/-18.11ms)。较长的 QTc 与更大的 LVEDD 相关。
39%的患者出现收缩期左心室功能障碍,反映出疾病的严重程度较高。所有患者中有三分之二出现舒张期左心室功能障碍的迹象,通常早于收缩期左心室功能障碍;因此,它可能被视为早期心脏疾病表现的指标,可能允许更早地进行治疗改变。常规心脏治疗无反应突出表明需要评估进一步的策略,如肝移植。